Gujarat Kidney and Super Speciality Limited Reports Robust Q2 FY27 Financial Results
Gujarat Kidney and Super Speciality Ltd · Investor Presentation · 05 Nov 2026, 3:30 am
Gujarat Kidney and Super Speciality Limited Reports Robust Q2 FY27 Financial Results Gujarat Kidney and Super Speciality reported a 194.6% YoY jump in Q2 FY27 revenue from operations to ₹3,809 lakhs (+11.1% QoQ), with PAT rising 129.4% YoY to ₹660 lakhs (+24.0% QoQ). EBITDA climbed 99.4% YoY to ₹1,022 lakhs, with margins expanding 239 bps QoQ to 26.8%. H1 FY27 revenue reached ₹7,238 lakhs, representing 88% of FY26 full-year revenue. The company maintains a net-cash balance sheet with ₹1,488 lakhs in net cash and deployed ₹1,669 lakhs toward H1 acquisitions, expanding across Gujarat and entering Dubai via Blue Tree Clinics.
Original exchange filing (PDF)
More announcements from Gujarat Kidney and Super Speciality Ltd
- Transcript of Earning Call conducted on 05/11/2026 · 11 Nov 2026
- Audio recording of earning call · 05 Nov 2026
- Revised presentation Uploaded for today''s Earning Con-Call. · 05 Nov 2026
- Statement of Deviation and Variation submitted for the quarter ended on September 30, 2026. · 05 Nov 2026
- Monitoring Report for the Quarter ended September 30, 2026 · 05 Nov 2026
- Unaudited Standalone and Consolidated Financial Results for the Quarter ended September 30, 2026 · 05 Nov 2026
- Gujarat Kidney And Super Speciality Limited has submitted to the Exchange, the unaudited Standalone and Consolidated financial results for the period ended September 30, 2026. · 05 Nov 2026
- Earning Con-call · 05 Nov 2026
